Skip to content

Clinical trials

Phase 2 Thyroid Cancer, Papillary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Cancer, Papillary Phase: Phase 2 Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20046
20051
20061
20072
20082
20123
20131
20142
20152
20182
20191
20202
20213
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting6
Terminated5
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)14
Academic and Community Cancer Research United2
Hoffmann-La Roche2
M.D. Anderson Cancer Center2
Massachusetts General Hospital2
Bhavana Konda1
City of Hope Medical Center1
Day One Biopharmaceuticals, Inc.1
Emory University1
H. Lee Moffitt Cancer Center and Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Cancer, Papillary35
Thyroid Neoplasms28
Adenocarcinoma, Follicular27
Carcinoma, Medullary9
Head and Neck Neoplasms7
Colorectal Neoplasms4
Melanoma4
Pancreatic Neoplasms4
Thyroid Carcinoma, Anaplastic4
Carcinoma, Non-Small-Cell Lung3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.